Finerenone in Heart Failure with Mildly Reduced or Preserved Ejection Fraction

Topics

Finerenone · Heart failure with preserved ejection fraction · Heart failure with mildly reduced ejection fraction · Nonsteroidal mineralocorticoid receptor antagonist · Steroidal mineralocorticoid receptor antagonists · Left ventricular ejection fraction · Cardiovascular death · Worsening heart failure events · Heart failure hospitalization · Urgent heart failure visit · Hyperkalemia · Hypokalemia · Randomized controlled trial · Double-blind randomized controlled trial · Composite Endpoint · Rate ratio · Hazard ratio · Placebo-controlled trial · Mineralocorticoid receptor antagonists · Cardiovascular safety · Heart failure morbidity and mortality · FINEARTS-HF trial · Guideline-Directed Medical Therapy · Multicenter trial · Recurrent event analysis · Drug safety · Composite Endpoint · Heart failure with preserved ejection fraction · Placebo · Time-to-event analysis